This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Here's Why You Should Add CME Group (CME) to Your Portfolio
by Zacks Equity Research
CME Group (CME) is poised to benefit from robust revenues and sound capital position.
Intercontinental Exchange Offers $2.5 Billion Senior Notes
by Zacks Equity Research
Intercontinental Exchange (ICE) displays prudence by issuing senior notes amid a low interest rate environment to procure funds.
Here's Why You Should Add Nasdaq (NDAQ) to Your Portfolio
by Zacks Equity Research
Nasdaq (NDAQ) is poised to grow over the long term given its operational excellence and growth initiatives.
MarketAxess Banks on High Revenues & Strong Capital Position
by Zacks Equity Research
MarketAxess (MKTX) is poised to benefit from strong revenues, robust trading volumes and sound liquidity position.
The Zacks Analyst Blog Highlights: Amazon, AstraZeneca, CME, Cisco and General Electric
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Amazon, AstraZeneca, CME, Cisco and General Electric
Top Stock Reports for Amazon, AstraZeneca & CME Group
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Amazon.com (AMZN), AstraZeneca (AZN) and CME Group (CME).
Cboe Global (CBOE) Q1 Earnings & Revenues Top Estimates
by Zacks Equity Research
Cboe Global's (CBOE) Q1 results reflect increased trading activity, decline in expenses and operational efficiencies.
All You Need to Know About CME (CME) Rating Upgrade to Buy
by Zacks Equity Research
CME (CME) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Intercontinental Exchange (ICE) Q1 Earnings Beat Estimates
by Zacks Equity Research
Intercontinental Exchange (ICE) Q1 results reflect record revenues, record operating income and double-digit earnings per share growth.
CME Group's (CME) Q1 Earnings Top Estimates, Revenues Up Y/Y
by Zacks Equity Research
CME Group's (CME) first-quarter 2020 results indicate strong revenues arising from increased volumes.
CME Group (CME) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
CME (CME) delivered earnings and revenue surprises of 4.48% and 1.37%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
CME Group (CME) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
CME Group's (CME) first-quarter 2020 performance is likely to have benefited from solid average daily volumes and higher revenues.
The Oil Price Plunge is an Opportunity to Learn About Options
by David Borun
Extreme situations like negative futures prices are an interesting way to learn about the mechanics of derivatives.
CME Group (CME) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
CME (CME) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Nasdaq (NDAQ) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Nasdaq's (NDAQ) Q1 results reflect growth in Market Services, Corporate Services, Information Services and Market Technology segments.
With Energy and Metals on the Move, Consider Commodity Options
by David Borun
Investors with and opinion on the direction of commodity prices should know all the facts before trading those options.
Nasdaq's (NDAQ) March Volumes Increase Year Over Year
by Zacks Equity Research
Nasdaq's (NDAQ) March U.S. equity options volume increases 45.4% and European options and futures volume rises 48.8% year over year.
The Zacks Analyst Blog Highlights: Procter & Gamble, AbbVie, QUALCOMM, PepsiCo and CME Group
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Procter & Gamble, AbbVie, QUALCOMM, PepsiCo and CME Group
CME Group's (CME) Volumes for March & Q1 Solid, Increase Y/Y
by Zacks Equity Research
CME Group's (CME) average daily volume for March and first-quarter 2020 increases on the back of better contribution by all six product lines.
Cboe Global's (CBOE) March Average Daily Volume Increases Y/Y
by Zacks Equity Research
Cboe Global's (CBOE) Options, Futures U.S. Equities, European Equities and Global Forex volume reflect y/y increases in March.
Top Analyst Reports for Procter & Gamble, AbbVie & QUALCOMM
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Procter & Gamble (PG), AbbVie (ABBV) and QUALCOMM (QCOM).
3 Stocks Immune to the Coronavirus Downturn to Buy Right Now
by Benjamin Rains
Today's episode of Full Court Finance here at Zacks quickly dives into why Wall Street seems optimistic on Monday. Despite the positivity, investors should still be on the hunt for stocks that appear immune to the broader coronavirus fallout...
Intercontinental Exchanges (ICE) March Volume Improves Y/Y
by Zacks Equity Research
Intercontinental Exchange's (ICE) March volume indicates improved Financial ADV, Commodities ADV and Energy ADV.
Buy Nasdaq (NDAQ) Stock for Safety Amid Coronavirus Market Volatility?
by Benjamin Rains
Nasdaq (NDAQ) shares have surged roughly 30% in the last two weeks and its earnings revisions have climbed amid the broader coronavirus economic downturn...
Why CME Group (CME) Stock Might be a Great Pick
by Zacks Equity Research
CME Group (CME) has seen solid earnings estimate revision activity over the past two months, and belongs to a strong industry as well.